Guidance for Industry InternetSocial Media latforms with Character Space Limitations Presenting Risk and Benefit Information for Prescription Drug s and Medical Device s DRAFT GUIDANCE This guidance - PDF document

Guidance for Industry InternetSocial Media latforms with Character Space Limitations Presenting Risk and Benefit Information for Prescription Drug s and Medical Device s DRAFT GUIDANCE This guidance - Description

Comments and suggestions regarding this draft document should be submitted within 90 days of publication in the Federal Register of the notice announcing the availability of the draft guidance Submit electronic comments to httpwwwregulationsgov Sub ID: 5898 Download Pdf

Download Section

Please download the presentation from below link :

Download Pdf - The PPT/PDF document "Guidance for Industry InternetSocial Med..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Embed / Share - Guidance for Industry InternetSocial Media latforms with Character Space Limitations Presenting Risk and Benefit Information for Prescription Drug s and Medical Device s DRAFT GUIDANCE This guidance

Presentation on theme: "Guidance for Industry InternetSocial Media latforms with Character Space Limitations Presenting Risk and Benefit Information for Prescription Drug s and Medical Device s DRAFT GUIDANCE This guidance "— Presentation transcript

pdf

Shom More....

Guidance for Industry InternetSocial Media latforms with Character Space Limitations Presenting Risk and Benefit Information for Prescription Drug s and Medical Device s DRAFT GUIDANCE This guidance - PDF document

Guidance for Industry InternetSocial Media latforms with Character Space Limitations Presenting Risk and Benefit Information for Prescription Drug s and Medical Device s DRAFT GUIDANCE This guidance - Description

Tags

Download Section

Presentation on theme: "Guidance for Industry InternetSocial Media latforms with Character Space Limitations Presenting Risk and Benefit Information for Prescription Drug s and Medical Device s DRAFT GUIDANCE This guidance "— Presentation transcript

Related documents

Guidance for Industry Fulfilling Regulatory Requirements for Postmarketing Submission s of Interactive Promotional Media for Prescription Human and Animal Drug and Biologics DRAFT GUIDANCE This guida PDF document

Guidance for Industry Naming of Drug Products Containing Salt Drug Substances DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only PDF document

Guidance for Industry Interim Product Reporting for Human Drug Compounding Outsourcing Facilities nder Section B of the Federal Food Drug and Cosmetic Act DRAFT GUIDANCE This guidance document is bei PDF document

Guidance for Industry Distributing Scientific and Medical Publications on Unapproved New Uses Recommended Practices REVISED DRAFT GUIDANCE This guidance document is being distributed for comment purpo PDF document

Draft Guidance for Industry and Food and Drug Administration Staff ... PDF document

Guidance for Industry Chronic Fatigue Syndrome Myalgic Encephalomyelitis Developing Drug Products for Treatment DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only PDF document

Guidance for Industry Developing Products for Weight Management DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only PDF document

Guidance for Industry How to Comply with the Pediatric Research Equity Act DRAFT GUIDANCE This guidance document is being distributed for comment purposes only PDF document

Guidance for Industry Applications for Premarket Review of New Tobacco Products DRAFT GUIDANCE This guidance docume t is being d stributed f r comment purposes only PDF document

Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs As DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only PDF document

Guidance for Industry and FDA Staff Submissions for Postapproval Modifications to a Combination Product Approved Under a BLA NDA or PMA DRAFT GUIDANCE This guidance document is being di stributed for PDF document

Guidance for Industry Complicated Intra Abdominal Infections Developing Drugs for Treatment DRAFT GUIDANCE This guidance document is being di stributed for comment purposes only PDF document